Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Chubb
Merck
Julphar
Johnson and Johnson
McKesson
Teva
Moodys
Cerilliant
Argus Health

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020819

« Back to Dashboard

NDA 020819 describes ZEMPLAR, which is a drug marketed by Abbvie and is included in two NDAs. It is available from three suppliers. There are two patents protecting this drug and three Paragraph IV challenges. Additional details are available on the ZEMPLAR profile page.

The generic ingredient in ZEMPLAR is paricalcitol. There are ten drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the paricalcitol profile page.
Summary for 020819
Tradename:ZEMPLAR
Applicant:Abbvie
Ingredient:paricalcitol
Patents:2
Therapeutic Class:Metabolic Bone Disease Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020819
Ingredient-typeCholecalciferol
Suppliers and Packaging for NDA: 020819
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819 NDA AbbVie Inc. 0074-1658 0074-1658-05 25 VIAL, MULTI-DOSE in 1 TRAY (0074-1658-05) > 2 mL in 1 VIAL, MULTI-DOSE
ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819 NDA AbbVie Inc. 0074-1658 0074-1658-01 25 VIAL, SINGLE-DOSE in 1 TRAY (0074-1658-01) > 1 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength0.005MG/ML (0.005MG/ML)
Approval Date:Apr 17, 1998TE:APRLD:Yes
Patent:➤ SubscribePatent Expiration:Oct 8, 2018Product Flag?Substance Flag?Delist Request?Y
Patent:➤ SubscribePatent Expiration:Oct 8, 2018Product Flag?Substance Flag?Delist Request?Y

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength0.002MG/ML (0.002MG/ML)
Approval Date:Feb 1, 2000TE:APRLD:Yes
Patent:➤ SubscribePatent Expiration:Oct 8, 2018Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 020819

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-002 Feb 1, 2000 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-001 Apr 17, 1998 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-003 Feb 1, 2000 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-002 Feb 1, 2000 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-002 Feb 1, 2000 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-001 Apr 17, 1998 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-001 Apr 17, 1998 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Fuji
Chubb
Covington
US Army
Accenture
UBS
McKesson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot